Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000820-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To examine the effect of peg-Intron dose by comparing the "standard" regimen, peg-Intron 1.5 mcg/kg qW sc plus ribavirin 800-1200 mg daily, to a lower dose regimen, peg-Intron 1.0 mcg/kg qW sc plus ribavirin 800-1200 mg daily, using a 24 week treatment duration for both arms, to examine the effect of duration of treatment by comparing the "standard" regimen, peg-Intron 1.5 mcg/kg qW sc plus ribavirin 800-1200 mg daily, using a 24 week treatment duration to the same regimen using a shorter treatment duration of 16 weeks.


Critère d'inclusion

  • Chronic Hepatitis C, Genotype 2 or 3

Liens